Cancer research includes companies engaged in scientific research on the causes, prevention, diagnosis, treatment, and potential cures for cancer. It involves many disciplines, from biology and genetics to clinical trials and drug development. These companies produce life-saving products for a rapidly growing and highly sought-after market and form strategic partnerships with global organizations. This makes them appealing to investors seeking both financial gain and support for healthcare advancements and patient outcomes.
Market Mover | Mesoblast Shares Surge 4% After Replacing Arcadium Lithium in the S&P/ASX 200 Index
AU Evening Wrap | ASX 200 Slips to a 5-Week Low on Bank Stocks Sell-Off; QBE Bucks the Trend with Strong Earnings
Market Mover | CSL shares fall 2%, facing significant selling pressure
AU Evening Wrap | ASX Surpasses 8200 as Fed Cuts Rates; BHP Rallies on Morgan Stanley Buy Rating
AU Evening Wrap | ASX Hits Record High Despite Slump in Rio Tinto and BHP
Earnings Call Summary | CSL LTD SPON ADR EACH REPR 0.5 ORD(CSLLY.US) Q4 2024 Earnings Conference